Blood Test to Help Determine the Efficacy of Anti-depressant

by Dr. Trupti Shirole on  December 18, 2011 at 4:00 PM Mental Health News   - G J E 4
A blood test for a protein called Vascular Endothelial Growth Factor (VEGF) can predict whether an anti-depressant drug will work on a depressed patient or not, according to researchers at the Loyola University Medical Center in Illinois, US.
 Blood Test to Help Determine the Efficacy of Anti-depressant
Blood Test to Help Determine the Efficacy of Anti-depressant

The study involved 35 patients who took the anti-depressant Escitalopram (selective serotonin reuptake inhibitors, SSRIs) for major depressive disorder. It was seen that more than 85% of depressed patients who had higher than normal blood levels of VEGF, experienced partial or complete relief after taking escitalopram, as compared to fewer than 10% of depressed patients who had low levels of VEGF responded to the drug.

Currently 60% of depression patients do not respond well to the first drug prescribed and it can take a month to achieve a drug response. Such blood tests promise a considerable improvement in time to benefit.

Lead author of the study, Angelos Halarissaid, "This would be the first time we would have a predictor for how well a patient would respond to an anti-depressant. It would greatly benefit our patients if we could predict ahead of time whether a given medication would be effective for a certain patient."

Presently VEGF blood test is very expensive, but the cost is likely to come down significantly if this test becomes widely used.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like